News Details

( As on 14/11/2025 07:22)

Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT Exclusivity in the U.S., the first product from its proprietary Long-Acting Injectable platform PrecisionSphere.